These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8480585)

  • 1. Coronary vasodilating action of dobutamine in patients with idiopathic dilated cardiomyopathy.
    Dubois-Randé JL; Merlet P; Duval-Moulin AM; Adnot S; Saal JP; Chabrier E; Castaigne A; Geschwind H
    Am Heart J; 1993 May; 125(5 Pt 1):1329-36. PubMed ID: 8480585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of calcitonin gene-related peptide on cardiac contractility, coronary hemodynamics and myocardial energetics in idiopathic dilated cardiomyopathy.
    Dubois-Randé JL; Merlet P; Benvenuti C; Sediame S; Macquin-Mavier I; Chabrier E; Braquet P; Castaigne A; Adnot S
    Am J Cardiol; 1992 Oct; 70(9):906-12. PubMed ID: 1388329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship among neuropeptide Y, catecholamines and haemodynamics in congestive heart failure.
    Dubois-Randé JL; Comoy E; Merlet P; Benvenuti C; Carville C; Hittinger L; Macquin-Mavier I; Bohuon C; Castaigne A
    Eur Heart J; 1992 Sep; 13(9):1233-8. PubMed ID: 1396834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct myocardial and coronary effects of enalaprilat in patients with dilated cardiomyopathy: assessment by a bilateral intracoronary infusion technique.
    Foult JM; Tavolaro O; Antony I; Nitenberg A
    Circulation; 1988 Feb; 77(2):337-44. PubMed ID: 2827913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dobutamine enhances cardiodepressant effects of receptor-mediated coronary endothelial stimulation.
    Bartunek J; Shah AM; Vanderheyden M; Paulus WJ
    Circulation; 1997 Jan; 95(1):90-6. PubMed ID: 8994422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of dobutamine and amrinone on coronary blood flow in patients with idiopathic dilated cardiomyopathy.
    Takeuchi M; Sonoda S; Himeno E; Tanaka S; Okazaki M; Nakashima Y; Kuroiwa A
    Cathet Cardiovasc Diagn; 1997 Jun; 41(2):157-63. PubMed ID: 9184288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome.
    Scrutinio D; Napoli V; Passantino A; Ricci A; Lagioia R; Rizzon P
    Eur Heart J; 2000 Jun; 21(11):927-34. PubMed ID: 10806017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic response to intracoronary infusion of atrial natriuretic factor in patients with normal or altered left ventricular function.
    Dubois-Rande JL; Adnot S; Benvenuti C; Merlet P; Hittinger L; Sediame S; Chabrier E; Braquet P; Castaigne A
    J Cardiovasc Pharmacol; 1991 Apr; 17(4):608-14. PubMed ID: 1711628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of beta-blockade and atropine on ischemic responses in left ventricular regions subtending coronary stenosis during dobutamine stress echocardiography.
    Chen L; Ma L; de Prada VA; Chen M; Feng YJ; Waters D; Gillam L; Chen C
    J Am Coll Cardiol; 1996 Dec; 28(7):1866-76. PubMed ID: 8962578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac energetics after intravenous enoximone in idiopathic dilated cardiomyopathy.
    Heiss HW; Hasenfuss G; Holubarsch C; Meinertz T; Just H
    Am J Cardiol; 1987 Aug; 60(5):53C-56C. PubMed ID: 2956869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dobutamine on left ventricular performance and myocardial metabolic demands in patients with ischemic heart disease.
    Côté P; Bourassa MG; Tubau JF; Enjalbert M; Vandormael M
    Clin Cardiol; 1984 Jan; 7(1):14-22. PubMed ID: 6705283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure.
    Sundell J; Engblom E; Koistinen J; Ylitalo A; Naum A; Stolen KQ; Kalliokoski R; Nekolla SG; Airaksinen KE; Bax JJ; Knuuti J
    J Am Coll Cardiol; 2004 Mar; 43(6):1027-33. PubMed ID: 15028362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial energetics and efficiency in patients with idiopathic cardiomyopathy: response to dobutamine and amrinone.
    Sundram P; Reddy HK; McElroy PA; Janicki JS; Weber KT
    Am Heart J; 1990 Apr; 119(4):891-8. PubMed ID: 2321508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy.
    Galderisi M; Cicala S; De Simone L; Caso P; Petrocelli A; Pietropaolo L; Celentano A; Mininni N; de Divitiis O
    Ital Heart J; 2001 Sep; 2(9):677-84. PubMed ID: 11666096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of dobutamine on ventriculo-arterial coupling and ventricular work efficiency in patients with cardiac failure].
    Ishizaka S; Asanoi H; Kameyama T; Sasayama S
    J Cardiol; 1988 Jun; 18(2):457-65. PubMed ID: 3249270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effects of dobutamine on myocardial oxygen consumption and cardiac efficiency measured using carbon-11 acetate kinetics in patients with dilated cardiomyopathy.
    Beanlands RS; Bach DS; Raylman R; Armstrong WF; Wilson V; Montieth M; Moore CK; Bates E; Schwaiger M
    J Am Coll Cardiol; 1993 Nov; 22(5):1389-98. PubMed ID: 8227796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the functional status of heart failure in non ischemic dilated cardiomyopathy: an echo-dobutamine study.
    Paraskevaidis IA; Tsiapras DP; Adamopoulos S; Kremastinos DT
    Cardiovasc Res; 1999 Jul; 43(1):58-66. PubMed ID: 10536690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures.
    Cannon RO; Rosing DR; Maron BJ; Leon MB; Bonow RO; Watson RM; Epstein SE
    Circulation; 1985 Feb; 71(2):234-43. PubMed ID: 4038383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of S-dobutamine on ischemic myocardium caused by coronary artery narrowing.
    Pollock GD; Bowling N; Tuttle RR; Hayes JS
    J Cardiovasc Pharmacol; 1994 Jul; 24(1):64-73. PubMed ID: 7521492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The differential effects of positive inotropic and vasodilator therapy on diastolic properties in patients with congestive cardiomyopathy.
    Carroll JD; Lang RM; Neumann AL; Borow KM; Rajfer SI
    Circulation; 1986 Oct; 74(4):815-25. PubMed ID: 3757193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.